Physician profile
Muhammad Ahmad
NPI 1801888953
$13,249.94
in general payments reported to CMS, 2019-2025
48 companies · $1,051 in 2025
The $1,051 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,086 · 2020: $777 · 2021: $1,085 · 2022: $5,178 · 2023: $1,036 · 2024: $1,036 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,123.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,555.12 | 2022 | |
| Abbott Laboratories | $2,190.62 | 2019-2025 | Cardiomems, Mitraclip, Dragonfly Opstar |
| Edwards Lifesciences Corporation | $1,199.18 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $1,169.28 | 2019-2025 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $1,146.37 | 2019-2025 | |
| Medtronic Vascular, INC. | $617.59 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $584.10 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $347.79 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $325.75 | 2019-2024 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $311.71 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $306.00 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $291.41 | 2020-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $267.91 | 2019-2025 | Brilinta, Andexxa |
| Cardiovascular Systems INC. | $202.41 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $182.19 | 2022-2025 | Verquvo, Capvaxive, Lagevrio |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.